257 related articles for article (PubMed ID: 29558726)
21. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome.
Porola P; Virkki L; Przybyla BD; Laine M; Patterson TA; Pihakari A; Konttinen YT
J Rheumatol; 2008 Nov; 35(11):2229-35. PubMed ID: 18843777
[TBL] [Abstract][Full Text] [Related]
22. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
[TBL] [Abstract][Full Text] [Related]
23. Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome.
Xiao L; Ng TB; Feng YB; Yao T; Wong JH; Yao RM; Li L; Mo FZ; Xiao Y; Shaw PC; Li ZM; Sze SC; Zhang KY
Phytomedicine; 2011 Jan; 18(2-3):194-8. PubMed ID: 20655712
[TBL] [Abstract][Full Text] [Related]
24. Cholinergic anti-inflammatory pathway in the non-obese diabetic mouse model.
Koopman FA; Vosters JL; Roescher N; Broekstra N; Tak PP; Vervoordeldonk MJ
Oral Dis; 2015 Oct; 21(7):858-65. PubMed ID: 26096224
[TBL] [Abstract][Full Text] [Related]
25. Updates on Sjögren's syndrome: from proteomics to protein biomarkers.
Baldini C; Cecchettini A; Gallo A; Bombardieri S
Expert Rev Proteomics; 2017 Jun; 14(6):491-498. PubMed ID: 28532233
[TBL] [Abstract][Full Text] [Related]
26. The Proteomics of Saliva in Sjögren's Syndrome.
Katsiougiannis S; Wong DT
Rheum Dis Clin North Am; 2016 Aug; 42(3):449-56. PubMed ID: 27431347
[TBL] [Abstract][Full Text] [Related]
27. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers. Saliva proteomics is a promising tool to study Sjögren syndrome.
Tzioufas AG; Kapsogeorgou EK
Nat Rev Rheumatol; 2015 Apr; 11(4):202-3. PubMed ID: 25668140
[TBL] [Abstract][Full Text] [Related]
29. A role for lymphotoxin in primary Sjogren's disease.
Shen L; Suresh L; Wu J; Xuan J; Li H; Zhang C; Pankewycz O; Ambrus JL
J Immunol; 2010 Nov; 185(10):6355-63. PubMed ID: 20952683
[TBL] [Abstract][Full Text] [Related]
30. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
31. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
32. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
33. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
[TBL] [Abstract][Full Text] [Related]
34. Quantitative proteomics of parotid saliva in primary Sjögren's syndrome.
Ambatipudi KS; Swatkoski S; Moresco JJ; Tu PG; Coca A; Anolik JH; Gucek M; Sanz I; Yates JR; Melvin JE
Proteomics; 2012 Oct; 12(19-20):3113-20. PubMed ID: 22888089
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.
Tensing EK; Ma J; Hukkanen M; Fox HS; Li TF; Törnwall J; Konttinen YT
Rheumatol Int; 2005 Jan; 25(1):28-32. PubMed ID: 13680143
[TBL] [Abstract][Full Text] [Related]
36. Correspondence between salivary proteomic pattern and clinical course in primary Sjögren syndrome and non-Hodgkin's lymphoma: a case report.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Ferro F; Galimberti S; Donati V; Bazzichi L; Bombardieri S; Lucacchini A
J Transl Med; 2011 Nov; 9():188. PubMed ID: 22047044
[TBL] [Abstract][Full Text] [Related]
37. Correlation between salivary secretion and salivary AQP5 levels in health and disease.
Wang D; Iwata F; Muraguchi M; Ooga K; Ohmoto Y; Takai M; Mori T; Ishikawa Y
J Med Invest; 2009; 56 Suppl():350-3. PubMed ID: 20224222
[TBL] [Abstract][Full Text] [Related]
38. Reduced salivary secretion contributes more to changes in the oral microbiome of patients with primary Sjögren's syndrome than underlying disease.
van der Meulen TA; Harmsen HJM; Bootsma H; Liefers SC; Vich Vila A; Zhernakova A; Weersma RK; Spijkervet FKL; Kroese FGM; Vissink A
Ann Rheum Dis; 2018 Oct; 77(10):1542-1544. PubMed ID: 29572289
[No Abstract] [Full Text] [Related]
39. Mapping Salivary Proteases in Sjögren's Syndrome Patients Reveals Overexpression of Dipeptidyl Peptidase-4/CD26.
Garreto L; Charneau S; Mandacaru SC; Nóbrega OT; Motta FN; de Araújo CN; Tonet AC; Modesto FMB; Paula LM; de Sousa MV; Santana JM; Acevedo AC; Bastos IMD
Front Immunol; 2021; 12():686480. PubMed ID: 34220840
[TBL] [Abstract][Full Text] [Related]
40. Salivary epidermal growth factor concentrations in patients with Sjögren syndrome and laryngopharyngeal reflux.
Eckley CA; Dos Anjos Corvo MA; Sardinha LR; Liquidato B; Rizzo LV
Ear Nose Throat J; 2017 Jun; 96(6):E6-E11. PubMed ID: 28636735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
